A case of doxifluridine-induced Ro/SSA-positive cutaneous lupus erythematosus

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Anti-Ro/SSA antibody positive drug-induced lupus erythematosus is characterized by erythematous papules at the photodistributed area after drug intake, positive anti-Ro/SSA antibody tests and histopathologic features of lupus erythematosus. A 68-year-old man was referred to our clinic with multiple erythematous violacious plaques on the face of 2 months' duration. After surgical removal of stomach cancer, he had been taking doxifluridine for 10 months. A histopathologic study revealed findings consistent with lupus erythematosus and the anti-Ro/SSA antibody was positive on the serologic test. Based on these findings, we diagnosed this case as anti-Ro/SSA antibody positive drug-induced lupus erythematosus, and report it with review of the literature.

Original languageEnglish
Pages (from-to)936-938
Number of pages3
JournalKorean Journal of Dermatology
Volume42
Issue number7
StatePublished - Jul 2004

Keywords

  • Anti-Ro/SSA
  • Doxifluridine
  • Drug-induced lupus erythematosus

Fingerprint

Dive into the research topics of 'A case of doxifluridine-induced Ro/SSA-positive cutaneous lupus erythematosus'. Together they form a unique fingerprint.

Cite this